A recent study investigating the association between dietary polyunsaturated fatty acid (PUFA) intake and estradiol levels in women in the United States utilized isotope dilution liquid chromatography–tandem mass spectrometry to measure serum estradiol levels.
A study conducted by Department of Urology of People’s Hospital of Xinjiang Uygur Autonomous Region (Ürümqi, China) and the Graduate School, of Zhejiang Chinese Medical University (Hangzhou, China) investigated the association between dietary polyunsaturated fatty acid (PUFA) intake and estradiol levels in women in the United States, with serum estradiol levels measured using isotope dilution liquid chromatography–tandem mass spectrometry (ID-LC–MS/MS). The findings suggested that higher intake of eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA) in non-menopausal women is associated with increased estradiol levels, which supports the importance of dietary components in regulating female reproductive health and hormone levels. A paper based on this study was recently published in Frontiers in Nutrition (1).
Estradiol is a crucial sex hormone in women, estradiol, which is produced by the ovaries, plays a significant role in sexual health and reproduction (2). Lower estradiol levels negatively impact both sexual and non-sexual aspects of an individual’s quality of life, with possible symptoms including low libido and difficulties in achieving orgasm (3–5). Non-sexual symptoms of lower estradiol levels include fatigue, poor concentration, depression, reduced muscle mass, weakened bone strength, and impaired iron metabolism (6-8). Due to these many wide-ranging effects, it is essential to address estradiol deficiency for overall health (9).
PUFAs are fatty acids containing two or more double bonds, with omega-3 and omega-6 as the primary types. Omega-3 fatty acids include α-linolenic acid (ALA), stearidonic acid (SDA), and docosahexaenoic acid (DHA), as well as EPA and DPA. Omega-6 fatty acids comprise linoleic acid (LA) and arachidonic acid (AA), both essential fatty acids primarily derived from crop seeds, vegetable oils, and cereal products (10,11). Though EPA and DHA are long-chain omega-3 fatty acids, they can also be synthesized from ALA (12). PUFAs maintain homeostasis in the body, and thus are essential, as an imbalance in the omega-6 to omega-3 ratio is associated with the development of a variety of diseases, including cardiovascular disease, cancer, inflammation, cardiovascular disease, and autoimmune disorders (13,14).
A total of 3095 women aged 20 years or older with complete data were included in this study. Weighted multivariate linear regressions showed positive associations between EPA and DPA intake and estradiol levels. Even in the fully adjusted model, EPA intake remained positively associated with estradiol levels in the menopausal (β = 78.08, 95% CI: 33.58, 122.58; p = 0.0006), non-menopausal (β = 287.61, 95% CI: 177.29, 397.94; p < 0.0001), and total-participant groups (β = 208.38, 95% CI: 139.81, 276.95; p < 0.0001), and DPA intake remained positively associated with estradiol levels in the non-menopausal (β = 318.87, 95% CI: 28.93, 608.82; p = 0.0313) and total-participant groups (β = 208.03, 95% CI: 22.89, 393.18; p = 0.0277). In the two-part regression model, EPA intake greater than 0.09 (p < 0.0001) and DPA intake greater than 0.05 (p = 0.0033) were positively associated with estradiol levels in non-menopausal women (1).
While the authors state that this study shows that estradiol levels in non-menopausal women increases with higher dietary intake of EPA and DPA, suggesting that dietary composition significantly influences women’s reproductive health and hormone regulation, further research is needed to clarify the mechanisms underlying these associations (1).
References
1. Guo, L.; Nan, Y.; Liang, K.; Yao, L.; Li, J. Association Between Polyunsaturated Fatty Acid Intake and Estradiol Levels Among U.S. Women. Front. Nutr. 2024, 11, 1500705. DOI: 10.3389/fnut.2024.1500705
2. Nelson, L. R.; Bulun, S. E. Estrogen Production and Action. J. Am. Acad. Dermatol. 2001, 45, S116–124. DOI: 10.1067/mjd.2001.117432
3. Burger, H. The Menopausal Transition—Endocrinology. J. Sex Med. 2008, 5, 2266–2273. DOI: 10.1111/j.1743-6109.2008.00921.x
4. Lara, L. A.; Cartagena-Ramos, D.; Figueiredo, J. B.; Rosa-E-Silva, A. C. J.; Ferriani, R. A.; Martins, W. P. et al. Hormone Therapy for Sexual Function in Perimenopausal and Postmenopausal Women. Cochrane Database Syst. Rev. 2023, 8, CD009672. DOI: 10.1002/14651858.CD009672.pub3
5. Bhasin, S.; Enzlin, P.; Coviello, A.; Basson, R. Sexual Dysfunction in Men and Women with Endocrine Disorders. Lancet 2007, 369, 597–611. DOI: 10.1016/S0140-6736(07)60280-3
6. Al-Azzawi, F.; Palacios, S. Hormonal Changes During Menopause. Maturitas 2009, 63, 135–137. DOI: 10.1016/j.maturitas.2009.03.009
7. Sun, Q.; Li, G.; Zhao, F.; Dong, M.; Xie, W.; Liu, Q, et al. Role of Estrogen in Treatment of Female Depression. Aging 2024, 16, 3021–3042. DOI: 10.18632/aging.205507
8. Kruger, M. C.; Coetzee, M.; Haag, M.; Weiler, H. Long-Chain Polyunsaturated Fatty Acids: Selected Mechanisms of Action on Bone. Prog. Lipid Res. 2010, 49, 438–449. DOI: 10.1016/j.plipres.2010.06.002
9. Shifren, J.L.; Gass, M. L. S. The North American Menopause Society Recommendations for Clinical Care of Midlife Women. Menopause 2014, 21, 1038–1062. DOI: 10.1097/GME.0000000000000319
10. Russo, G. L. Dietary n-6 and n-3 Polyunsaturated Fatty Acids: From Biochemistry to Clinical Implications in Cardiovascular Prevention. Biochem. Pharmacol. 2009, 77, 937–946. DOI: 10.1016/j.bcp.2008.10.020
11. Liu, Y.; Li, C. Hormone Therapy and Biological Aging in Postmenopausal Women. JAMA Netw Open. 2024, 7, e2430839. DOI: 10.1001/jamanetworkopen.2024.30839
12. Tocher, D. R.; Betancor, M. B.; Sprague, M.; Olsen, R. E.; Napier, J. A. Omega-3 Long-Chain Polyunsaturated Fatty acids, EPA and DHA: Bridging the Gap Between Supply and Demand. Nutrients 2019, 11, 89. DOI: 10.3390/nu11010089
13. Kang, J. X.; Liu, A. The Role of the Tissue Omega-6/Omega-3 Fatty Acid Ratio in Regulating Tumor Angiogenesis. Cancer Metastasis Rev. 2013, 32, 201–210. DOI: 10.1007/s10555-012-9401-9
14. Dennis, E. A.; Norris, P. C. Eicosanoid Storm in Infection and Inflammation. Nat. Rev. Immunol. 2015, 15, 511–523. DOI: 10.1038/nri3859
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.